Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Stifel Downgrades Momenta Pharmaceuticals to Hold, Raises Price Target to $52.5


Benzinga | Aug 20, 2020 06:20AM EDT

Stifel Downgrades Momenta Pharmaceuticals to Hold, Raises Price Target to $52.5

Stifel analyst Derek Archila downgrades Momenta Pharmaceuticals (NASDAQ:MNTA) from Buy to Hold and raises the price target from $47 to $52.5.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC